The Scientific Advisory Board Will Develop the Company Clinical Trial Strategy, Ensure Alignment with Current Trends in Cardiac Pacing for Heart Failure Patients and Provide Input to the Pacertool Innovation Pipeline. Oslo, Norway, October 4th, 2022Pacertool AS, a Norwegian emerging medical device company, today announced that the company has established a world-class Scientific Advisory Board (SAB), which […]
We are pleased to announce that Pacertool has been granted 7.5M NOK by the Research Council of Norway for the Precision at the Heart of Heart Failure project, to contribute to the final R&D of the PaCRTool-System and initiate clinical regulatory activities. The grant is provided as an Innovation Project for the Industrial Sector and […]
You can write your own excerpt in the excerpt-field. The field is located within the menu on the right hand side, while editing your blogpost. This is great if you want to inform the reader of the key points in your text, before clicking on the link.
Pacertool Biomarker in EHRA 2021 The annual congress of the European Heart Rhythm Association was held online this year, but that did not hinder it from being as successful as ever with key opinion leaders in the field and top scientists from all over the world interconnected seamlessly. On top of that, all presentations are […]
Heart Rhythm 2021 – Pacertool Biomarker The Pacertool Biomarker was presented in four different posters at the annual Heart Rhythm Society meeting in Boston July 2021. The posters highlight the Biomarker nature of the proprietary Pacertool measurement (Time delay to peak Left Ventricular Pressure Rise -Td) that with high precision detects patients amenable to Cardiac […]